NAPLEX Quiz: Self Monitoring And Administration Devices

What this quiz covers

This quiz focuses on Self Monitoring And Administration Devices, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Have her take readings only after meals because postprandial blood pressure best reflects orthostatic symptoms
2. Recommend wrist-cuff measurement with the wrist below heart level to simplify technique
3. Instruct her to measure after resting supine or seated, then again within 1 to 3 minutes of standing, documenting symptoms and readings for the prescriber (correct answer)
4. Tell her to inflate the cuff as high as possible each time to improve accuracy

Explanation: This question addresses proper blood pressure monitoring technique for detecting orthostatic hypotension. The patient's dizziness on multiple antihypertensives requires systematic evaluation for positional blood pressure changes. Orthostatic assessment requires measuring blood pressure after resting supine or seated, then repeating within 1-3 minutes of standing, documenting both readings and associated symptoms to identify clinically significant drops (choice C is correct). Postprandial measurements assess different physiology (postprandial hypotension) and don't evaluate orthostatic changes (choice A is incorrect). Wrist cuffs are less accurate than upper arm devices, and positioning below heart level produces falsely elevated readings (choice B is incorrect). Excessive cuff inflation causes discomfort without improving accuracy and may trigger anxiety-related blood pressure elevation (choice D is incorrect). The diagnostic framework defines orthostatic hypotension as a drop of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing, requiring standardized positioning measurements.

Question 2

1. Check only once weekly at a random time because hemoglobin A1c reflects overall control
2. Check at least before meals and at bedtime, and consider occasional post-meal checks to guide mealtime insulin dosing and detect hypoglycemia (correct answer)
3. Check only 2 hours after each meal because pre-meal values are not useful for insulin adjustment
4. Check only when symptoms occur because routine self-monitoring is not recommended for patients using insulin

Explanation: This question addresses blood glucose monitoring frequency for patients on basal-bolus insulin therapy. The patient's elevated A1c (9.1%) and use of both basal and mealtime insulin requires frequent monitoring to guide insulin adjustments and detect hypoglycemia. Checking before meals provides pre-prandial values to guide mealtime insulin dosing, bedtime checks ensure safe overnight glucose levels, and occasional post-meal checks assess mealtime insulin effectiveness (choice B is correct). Weekly random checks are insufficient for insulin users who need daily data for dose adjustments (choice A is incorrect). Checking only post-meal values misses pre-meal hypoglycemia and doesn't provide baseline values for mealtime insulin dosing (choice C is incorrect). Symptom-based checking alone is dangerous as hypoglycemia unawareness can develop, and hyperglycemia may be asymptomatic (choice D is incorrect). The clinical framework is that insulin users should monitor at least 4 times daily (before meals and bedtime) with additional checks as needed based on symptoms, activity changes, or dose adjustments.

Question 3

1. Apply the patch to irritated or broken skin to improve absorption and speed onset
2. Cut the patch in half if she feels too sleepy so she can lower the dose safely
3. Apply to clean, dry, hairless skin; press firmly for about 30 seconds; avoid heat sources (heating pads, hot baths) and remove the old patch before applying a new one (correct answer)
4. Change the patch daily to prevent end-of-dose pain and maintain steady analgesia

Explanation: This question addresses safe transdermal fentanyl patch application and use to prevent adverse effects. The patient is opioid-tolerant (already on the patch) but needs proper technique education for safety. Correct application involves clean, dry, hairless skin with firm pressure for 30 seconds to ensure adhesion, avoiding heat sources that increase absorption and overdose risk, and removing old patches before applying new ones to prevent dose stacking (choice C is correct). Applying to broken skin increases systemic absorption unpredictably and can cause toxicity (choice A is incorrect). Cutting fentanyl patches destroys the drug delivery system, causing immediate release of the entire dose with potentially fatal consequences (choice B is incorrect). Fentanyl patches are changed every 72 hours, not daily, as they provide sustained release over 3 days (choice D is incorrect). The critical safety principle is that fentanyl patches must never be cut, heated, or applied to damaged skin, and old patches must be removed to prevent accumulation.

Question 4

1. Serum potassium weekly to assess for warfarin-related electrolyte changes
2. INR results along with assessment for bleeding or bruising and adherence to consistent vitamin K intake (correct answer)
3. Activated partial thromboplastin time (aPTT) results to ensure adequate anticoagulation
4. Platelet count daily to monitor for heparin-induced thrombocytopenia

Explanation: This question tests understanding of appropriate monitoring parameters for home INR devices in warfarin therapy. The patient wants to self-monitor INR at home, which requires understanding what to monitor beyond just the numerical result. INR monitoring must include assessment for bleeding signs/symptoms and maintaining consistent vitamin K intake, as dietary changes can affect warfarin's anticoagulant effect (choice B is correct). Warfarin does not cause electrolyte changes, and potassium monitoring is not indicated for warfarin therapy (choice A is incorrect). aPTT monitors heparin therapy, not warfarin, which is monitored via INR/PT (choice C is incorrect). Daily platelet monitoring for HIT is relevant to heparin therapy, not warfarin, and would require laboratory testing not available on home devices (choice D is incorrect). The key principle is that home INR monitoring must be coupled with clinical assessment for bleeding and dietary consistency to ensure safe and effective anticoagulation.

Question 5

1. Recommend using expired test strips first to avoid waste, since readings remain accurate for several months past expiration
2. Advise him to store test strips in the original closed vial, check expiration, wash and dry hands before testing, and use an adequate blood sample size per the meter instructions (correct answer)
3. Tell him to wipe the test strip with an alcohol swab before inserting it to prevent contamination
4. Instruct him to apply blood to the top of the strip after the meter times out, because the device will still accept the sample

Explanation: This question tests troubleshooting of glucometer errors and ensuring accurate blood glucose monitoring. The patient's error messages and unexpectedly low readings suggest problems with test strip handling or storage. Proper technique includes storing strips in original closed containers to prevent moisture exposure, checking expiration dates, washing and drying hands to remove contaminants, and using adequate blood sample size per manufacturer specifications (choice B is correct). Using expired test strips produces inaccurate results as the enzyme reagents degrade over time (choice A is incorrect). Wiping strips with alcohol can damage the reagent area and interfere with the chemical reaction needed for accurate measurement (choice C is incorrect). Applying blood after the meter times out will not produce a reading as the strip's enzyme reaction has a limited active window (choice D is incorrect). The key principle is that test strip integrity and proper sampling technique are critical for accurate readings, with most errors stemming from expired strips, contamination, or insufficient sample volume.

Question 6

1. Measure blood pressure immediately after exercise to capture the highest daily reading
2. Place the cuff over clothing to reduce skin irritation and improve comfort
3. Use the correct cuff size on a bare upper arm, sit quietly for 5 minutes with back supported and arm at heart level, and take two readings 1 minute apart (correct answer)
4. Take one reading while standing to better reflect blood pressure during daily activities

Explanation: This question evaluates proper home blood pressure monitoring technique for accurate readings. The patient's elevated clinic reading (154/92 mmHg) necessitates accurate home monitoring to guide therapy adjustments. Proper technique includes using correct cuff size on bare skin, sitting quietly for 5 minutes with back supported and feet flat, positioning arm at heart level, and taking two readings 1 minute apart then averaging them (choice C is correct). Measuring immediately after exercise captures artificially elevated readings due to physiological response, not reflecting resting blood pressure (choice A is incorrect). Placing cuff over clothing interferes with accurate readings by creating uneven pressure distribution (choice B is incorrect). Standing measurements are used specifically to assess orthostatic changes, not routine monitoring, and single readings are less reliable than averaged multiple readings (choice D is incorrect). The clinical pearl is that standardized technique with proper positioning, rest period, and multiple readings ensures reproducible measurements for treatment decisions.

Question 7

1. Counsel the patient to inhale quickly and forcefully immediately after actuating the MDI to maximize throat deposition
2. Recommend actuating two puffs into the air before every dose to ensure the inhaler is full
3. Demonstrate: exhale fully, actuate the inhaler at the start of a slow deep inhalation, hold breath about 10 seconds, and wait about 1 minute between puffs (correct answer)
4. Instruct the patient to skip shaking the inhaler because shaking can cause inaccurate dosing

Explanation: This question tests proper inhalation technique for metered-dose inhalers (MDIs) in asthma management. The key patient-specific factor is the patient's report of ineffective albuterol MDI relief, with reduced peak flow indicating possible improper device use. Demonstrating to exhale fully, actuate the inhaler at the start of a slow deep inhalation, hold breath about 10 seconds, and wait about 1 minute between puffs is the best choice as it optimizes lung deposition and medication efficacy. Counseling to inhale quickly and forcefully is incorrect because it increases throat deposition and reduces lung delivery; actuating two puffs into the air before every dose wastes medication and is unnecessary; skipping shaking is suboptimal as most MDIs require shaking to mix the propellant and drug. Using a spacer can further improve MDI technique for patients with coordination issues. A transferable clinical pearl is to assess and retrain inhaler technique at every visit, as poor technique is a common cause of uncontrolled asthma symptoms.

Question 8

1. Daily serum potassium to detect hyperkalemia from warfarin therapy
2. Regular comparison of home INR results with a laboratory INR (per protocol) to verify meter accuracy (correct answer)
3. Weekly fasting lipid panel to assess anticoagulant response
4. Monthly urine glucose to confirm device calibration

Explanation: This question tests monitoring requirements for home INR self-testing devices in patients on warfarin. The key patient-specific factor is the initiation of home monitoring due to clinic no-shows, with concurrent amiodarone increasing INR variability. Regular comparison of home INR results with a laboratory INR (per protocol) to verify meter accuracy is the best choice as it ensures reliable results and safe anticoagulation management. Daily serum potassium is unnecessary as warfarin does not directly affect potassium; weekly fasting lipid panels are irrelevant to anticoagulant response; monthly urine glucose does not confirm calibration. Home INR testing can improve adherence but requires periodic lab correlation. A clinical pearl is to establish a protocol for home INR validation, especially with interacting drugs, to prevent over- or under-anticoagulation.

Question 9

1. Apply the patch for 12 hours on and 12 hours off, and apply only to intact skin over the painful area (correct answer)
2. Wear the patch continuously for 24 hours for maximum analgesia
3. Apply the patch directly after bathing while the skin is wet to improve adherence and absorption
4. Use a heating pad over the patch to enhance penetration and speed onset

Explanation: This question tests appropriate wear time and application for lidocaine transdermal patches in neuralgia. The key patient-specific factor is use for postherpetic neuralgia on intact skin, requiring limited exposure to avoid systemic effects. Applying the patch for 12 hours on and 12 hours off, and only to intact skin over the painful area is the best choice as it provides analgesia while minimizing toxicity per labeling. Wearing continuously increases absorption risk; applying to wet skin reduces adhesion; using heat can cause burns or overdose. Cut to fit if needed but do not overlap. A clinical pearl is to adhere to on/off schedules for topical anesthetics to balance efficacy and safety.

Question 10

1. Roll the pen gently between the hands and invert it several times to resuspend the insulin before injecting (correct answer)
2. Avoid mixing or rolling; cloudy insulin should be clear before injection
3. Prime the pen once weekly only to conserve insulin
4. Inject NPH intravenously for faster onset at bedtime

Explanation: This question tests preparation technique for cloudy insulin pens like NPH. The key patient-specific factor is the new NPH pen prescription with elevated A1c, requiring proper mixing for uniform dosing. Rolling the pen gently between the hands and inverting it several times to resuspend the insulin before injecting is the best choice as NPH is a suspension that settles and needs gentle mixing. Avoiding mixing is incorrect as it leads to inconsistent dosing; priming weekly wastes insulin and risks errors; injecting intravenously is dangerous and not indicated. Inspect for uniform cloudiness after mixing. A decision framework is to differentiate clear vs. cloudy insulins and apply appropriate preparation techniques to ensure therapeutic efficacy.

Question 11

1. More frequent INR checks during initiation of interacting medications that can raise INR and bleeding risk (correct answer)
2. Daily hemoglobin A1c to evaluate anticoagulation control
3. Monthly thyroid-stimulating hormone to ensure INR meter accuracy
4. Weekly serum magnesium to prevent warfarin-induced arrhythmias

Explanation: This question tests monitoring adjustments for home INR devices with drug interactions. The key patient-specific factor is the recent start of trimethoprim-sulfamethoxazole, which can potentiate warfarin and elevate INR. More frequent INR checks during initiation of interacting medications that can raise INR and bleeding risk is the best choice to detect changes promptly and adjust dosing. Daily A1c is irrelevant; monthly TSH does not ensure accuracy; weekly magnesium is not related to warfarin. Identify interactions and increase monitoring frequency. A clinical pearl is to use interaction checkers and protocol-driven INR testing to manage risks in polypharmacy patients.

Question 12

1. Fasting blood glucose readings (with date/time) to evaluate basal insulin effectiveness and guide titration (correct answer)
2. Random urine ketones weekly to validate the glucometer result
3. Daily body temperature to assess for glucometer malfunction
4. Monthly serum sodium to confirm strip accuracy

Explanation: This question tests appropriate parameters for self-monitoring of blood glucose in basal insulin users. The key patient-specific factor is the request for SMBG to guide dose adjustments in a patient with elevated A1c on glargine. Fasting blood glucose readings (with date/time) to evaluate basal insulin effectiveness and guide titration is the best choice as it targets overnight control for safe adjustments. Random urine ketones are not routine; daily temperature is irrelevant; monthly sodium does not confirm accuracy. Log patterns and symptoms. A decision framework is to tailor SMBG frequency and timing to therapy goals, such as fasting for basal insulin titration.

Question 13

1. Exhale into the mouthpiece before inhaling to help disperse the powder dose
2. Inhale rapidly and deeply through the device after loading the dose, then hold the breath about 10 seconds (correct answer)
3. Use a spacer device with the DPI to improve delivery to the lungs
4. Rinse the mouthpiece with water after each dose and store it while still wet to prevent static

Explanation: This question tests proper technique for dry powder inhalers (DPIs) in asthma control. The key patient-specific factor is the new DPI prescription for daily budesonide, with moderate albuterol use suggesting need for correct inhalation to optimize therapy. Inhaling rapidly and deeply through the device after loading the dose, then holding the breath about 10 seconds is the best choice as DPIs require forceful inhalation to disperse the powder effectively into the lungs. Exhaling into the mouthpiece contaminates the dose; using a spacer is incompatible with DPIs; rinsing and storing wet promotes bacterial growth. Rinse mouth after use to prevent thrush. A clinical pearl is that DPI efficacy depends on patient-generated inspiratory flow, so assess technique and consider alternatives for those with low flow rates.

Question 14

1. Train the patient and a caregiver to reconstitute glucagon only when needed, inject intramuscularly or subcutaneously per product instructions, and call emergency services if severe hypoglycemia occurs (correct answer)
2. Instruct the patient to use glucagon daily before breakfast to prevent low blood sugar episodes
3. Advise storing the reconstituted glucagon syringe at room temperature for up to 30 days for convenience
4. Recommend administering glucagon by inhaling the powder from the vial for faster absorption

Explanation: This question tests the pharmacist's role in educating patients on the proper use of glucagon emergency kits for treating severe hypoglycemia in type 1 diabetes. The key patient-specific factor is the recent episode of severe hypoglycemia requiring assistance, necessitating an emergency intervention that the patient may not be able to self-administer. Choice A is the best action because it emphasizes training both the patient and a caregiver on reconstituting glucagon only at the time of need, administering it correctly via intramuscular or subcutaneous injection, and seeking immediate medical help, which aligns with safe and effective use in emergencies. Choice B is incorrect because glucagon is not for daily preventive use but reserved for acute severe hypoglycemia when oral carbohydrates cannot be given. Choice C is suboptimal as reconstituted glucagon should be used immediately and discarded, not stored at room temperature for up to 30 days due to stability issues; choice D is wrong because glucagon kits are for injection, not inhalation of powder from the vial, which is ineffective and unsafe. A key clinical pearl is that glucagon administration should always be followed by emergency medical services contact, as it provides temporary relief and underlying causes need evaluation. Pharmacists should routinely verify patient and caregiver understanding of emergency devices through teach-back methods to prevent misuse.

Question 15

1. Recommend a validated upper-arm monitor and measure mid-arm circumference to select the correct cuff size (correct answer)
2. Recommend the smallest cuff available because tighter cuffs provide more accurate readings
3. Recommend a finger blood pressure monitor because it is the standard for home monitoring accuracy
4. Advise taking readings while talking to simulate normal daily activity and avoid falsely low readings

Explanation: This question tests selection and sizing of home blood pressure monitors for accurate hypertension diagnosis. The key patient-specific factor is the new diagnosis in an overweight patient, where cuff size affects reading accuracy. Recommending a validated upper-arm monitor and measuring mid-arm circumference to select the correct cuff size is the best choice as improper sizing can lead to falsely high or low readings. Small cuffs overestimate pressure; finger monitors are less accurate; measuring while talking elevates readings artificially. Use validated devices from reputable sources. A decision framework is to match cuff size to arm circumference (e.g., 22-32 cm for standard) to ensure reliable home monitoring and guide therapy.

Question 16

1. Advise the patient to store the in-use pen in the freezer to preserve potency and reduce injection discomfort
2. Instruct the patient to prime the pen with 2 units and confirm a visible insulin drop before each injection, then dial and inject the prescribed dose (correct answer)
3. Tell the patient to reuse the same pen needle for up to 1 week as long as the cap is replaced between injections
4. Recommend mixing insulin glargine by vigorously shaking the pen for 10 seconds before each use

Explanation: This question tests proper administration technique for insulin glargine prefilled pens in patients with type 2 diabetes. The key patient-specific factor is the initiation of a new insulin pen device with elevated fasting glucose and A1c, requiring education on correct use to ensure efficacy and safety. Instructing the patient to prime the pen with 2 units and confirm a visible insulin drop before each injection, then dial and inject the prescribed dose, is the best choice because it removes air bubbles, ensures accurate dosing, and prevents underdosing. Advising storage in the freezer is incorrect as it can damage the insulin and increase injection pain; reusing the same needle for up to 1 week risks contamination and needle dulling; recommending vigorous shaking is suboptimal because insulin glargine is a clear solution that does not require mixing. Storing in-use pens at room temperature and using a new needle for each injection are essential to maintain insulin stability and reduce infection risk. A useful decision framework is to always demonstrate pen priming and injection technique during initial training and have the patient return-demonstrate to confirm understanding.

Question 17

1. Confirm the patient knows the test strip expiration date and to keep strips in the original closed vial to protect from moisture (correct answer)
2. Recommend storing test strips in the refrigerator door to maintain accuracy
3. Advise using alcohol on the fingertip and testing while the alcohol is still wet to disinfect and improve blood flow
4. Tell the patient to use alternate site testing only (forearm) for suspected hypoglycemia because it changes faster than fingertip blood

Explanation: This question tests storage and handling of glucometer test strips for accurate blood glucose monitoring. The key patient-specific factor is the start of a new glucometer with multiple insulin doses, requiring reliable readings for dose adjustments. Confirming the patient knows the test strip expiration date and to keep strips in the original closed vial to protect from moisture is the best choice as it prevents degradation and ensures accurate results. Storing in the refrigerator can cause condensation and errors; using alcohol while wet dilutes the sample; alternate site testing is less sensitive for rapid changes like hypoglycemia. Use fingertip for suspected lows and check control solution regularly. A decision framework is to always verify strip integrity and storage to minimize false readings that could lead to inappropriate insulin dosing.

Question 18

1. Exhale fully, place the mouthpiece, start a slow deep inhalation while pressing the canister once, then hold the breath for about 10 seconds (correct answer)
2. Inhale as fast and forcefully as possible immediately after pressing the canister to deliver the full dose
3. Press the canister twice in rapid succession during a single inhalation to improve lung deposition
4. Exhale into the inhaler mouthpiece before actuating to reduce static and improve dosing accuracy

Explanation: This question evaluates proper metered-dose inhaler (MDI) technique for optimal bronchodilator delivery. The patient's suboptimal peak flow (76% of personal best) despite having medication suggests poor inhaler technique is limiting drug delivery. Correct MDI technique involves exhaling fully, placing lips around the mouthpiece, beginning a slow deep inhalation while simultaneously pressing the canister once, then holding breath for 10 seconds to allow medication deposition in the lungs (choice A is correct). Fast, forceful inhalation causes medication to impact the throat rather than reach the lungs, reducing efficacy (choice B is incorrect). Pressing the canister twice during one inhalation delivers excessive medication and wastes doses without improving deposition (choice C is incorrect). Exhaling into the inhaler can introduce moisture that affects the valve mechanism and dose delivery (choice D is incorrect). The key principle is that slow, deep inhalation coordinated with actuation optimizes lung deposition, while breath-holding allows settling of medication particles in the airways.

Question 19

1. Inject insulin lispro immediately after finishing the meal to reduce the risk of hypoglycemia in all situations
2. Rotate injection sites within the same general area and administer insulin lispro within about 15 minutes before eating (or right after if a meal is uncertain) to match mealtime glucose rise (correct answer)
3. Use the same exact injection spot each time to ensure consistent absorption and predictable action
4. Mix insulin lispro and insulin glargine together in the same pen injection to reduce the number of daily injections

Explanation: This question tests mealtime insulin administration timing and injection site rotation for type 1 diabetes management. The patient's elevated A1c (8.4%) indicates need for optimized insulin technique including proper timing and site rotation. Rapid-acting insulin should be given within 15 minutes before meals to match peak action with postprandial glucose rise, though can be given immediately after if meal intake is uncertain, while rotating sites within the same anatomical region prevents lipodystrophy (choice B is correct). Routinely giving insulin after meals delays action relative to glucose rise, worsening postprandial control except when meal intake is uncertain (choice A is incorrect). Using the exact same spot repeatedly causes lipodystrophy, creating unpredictable absorption and poor glycemic control (choice C is incorrect). Insulin glargine cannot be mixed with other insulins due to its acidic pH, and mixing would alter both insulins' pharmacokinetics (choice D is incorrect). The clinical principle is that mealtime insulin timing should match its pharmacokinetic peak with food absorption while systematic rotation within anatomical regions maintains consistent absorption.

Question 20

1. Instruct him to inject, then immediately remove the needle without holding the pen in place to reduce bruising
2. Have him perform a safety test (prime) with 2 units before each injection and confirm he holds the needle in the skin for about 10 seconds after pressing the dose button (correct answer)
3. Advise him to reuse the same pen needle for up to 1 week as long as it looks clean and the cap is replaced
4. Tell him to store the in-use pen in the refrigerator between injections to maintain potency

Explanation: This question tests proper insulin pen technique and safety procedures for optimal drug delivery. The patient is transitioning from vials to pens and needs education on correct device use to ensure therapeutic efficacy. Performing a safety test (priming) with 2 units before each injection removes air bubbles and ensures proper flow, while holding the needle in place for 10 seconds after injection allows complete dose delivery and prevents insulin leakage (choice B is correct). Immediately removing the needle without holding can cause insulin to leak back out, resulting in incomplete dosing (choice A is incorrect). Reusing pen needles increases infection risk, causes needle dulling leading to painful injections, and can clog the needle with crystallized insulin (choice C is incorrect). In-use insulin pens should be stored at room temperature for up to 28-30 days, as refrigeration can cause condensation and affect dosing accuracy (choice D is incorrect). The clinical pearl is that proper pen technique includes priming before each use and maintaining needle placement for 10 seconds to ensure complete dose delivery.